PharmaRoth Labs, Inc. Stock Other OTC
Equities
ROTH
US71715Y1029
Pharmaceuticals
Sales 2009 | - | Sales 2010 | - | Capitalization | 5.74M 7.9M |
---|---|---|---|---|---|
Net income 2009 | - 0 | Net income 2010 | - 0 | EV / Sales 2009 | - |
Net Debt 2009 | 12.5K 17.21K | Net Debt 2010 | 286K 394K | EV / Sales 2010 | - |
P/E ratio 2009 |
-777
x | P/E ratio 2010 |
-7.8
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 30.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 13-01-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 |
1st Jan change | Capi. | |
---|---|---|
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |